AXMIX
Price
$15.58
Change
-$0.10 (-0.64%)
Updated
Sep 20 closing price
VMCIX
Price
$71.53
Change
-$0.13 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

AXMIX vs VMCIX

Header iconAXMIX vs VMCIX Comparison
Open Charts AXMIX vs VMCIXBanner chart's image
Acclivity Mid Cap Multi-Style I
Price$15.58
Change-$0.10 (-0.64%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Institutional
Price$71.53
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AXMIX vs VMCIX Comparison Chart
Loading...
VS
AXMIX vs. VMCIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXMIX is a StrongBuy and VMCIX is a Buy.

FUNDAMENTALS
Fundamentals
VMCIX has more cash in the bank: 172B vs. AXMIX (4.43M). VMCIX pays higher dividends than AXMIX: VMCIX (1.50) vs AXMIX (0.54). AXMIX was incepted earlier than VMCIX: AXMIX (5 years) vs VMCIX (26 years). AXMIX is a more actively managed with annual turnover of: 53.00 vs. VMCIX (13.00). AXMIX has a lower initial minimum investment than VMCIX: AXMIX (20000) vs VMCIX (5000000). AXMIX annual gain was more profitable for investors over the last year : 24.74 vs. VMCIX (20.58).
AXMIXVMCIXAXMIX / VMCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years26 years-
Gain YTD14.12711.336125%
Front LoadN/AN/A-
Min. Initial Investment2000050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.43M172B0%
Annual Yield % from dividends0.541.5036%
Returns for 1 year24.7420.58120%
Returns for 3 years24.376.80358%
Returns for 5 yearsN/A55.18-
Returns for 10 yearsN/A122.16-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRGV1.000.03
+2.76%
Energy Vault Holdings
ELVN21.760.29
+1.35%
Enliven Therapeutics
HIG116.70-0.37
-0.32%
Hartford Financial Services Group (The)
FOUR83.58-0.36
-0.43%
Shift4 Payments
CUE0.55-0.02
-2.86%
Cue Biopharma